WASHINGTON (AP) — Drugmaker Pfizer has agreed to lower drug costs under a deal struck with President Donald Trump’s administration. Trump made the announcement Tuesday with Pfizer CEO Albert Bourla at the White House. The announcement comes as the Republican president has for months sought to lower drug costs and as Washington faces a possible federal government shutdown amid a standoff between Democrats and Republicans over health care and its costs. Trump says that under the agreement, New York-based Pfizer will charge most-favored-nation pricing to Medicaid and guarantee the same pricing on newly launched drugs. That involves matching the lowest price offered in other developed nations. Trump says similar deals will be struck with other drugmakers facing a threat of tariffs.… Continue Reading
